Shandong Realcan Pharmaceutical Co Ltd (002589) — Cash Flow-to-Debt Ratio
Shandong Realcan Pharmaceutical Co Ltd (002589) has a Cash Flow-to-Debt Ratio of 0.00x as of September 2025, meaning its operating cash flow of CN¥-15.60 Million could theoretically repay 0% of its total liabilities (CN¥9.87 Billion) in one year. Explore Shandong Realcan Pharmaceutical Co Ltd strategic investment ratio to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Shandong Realcan Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio (2008–2025)
Historical debt coverage capacity for Shandong Realcan Pharmaceutical Co Ltd across 18 annual periods. Also explore Shandong Realcan Pharmaceutical Co Ltd asset portfolio for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Shandong Realcan Pharmaceutical Co Ltd (2008–2025)
Year-by-year debt coverage analysis for Shandong Realcan Pharmaceutical Co Ltd. For market capitalisation and broader financial context, see Shandong Realcan Pharmaceutical Co Ltd market cap and net worth.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.00x | CN¥13.76 Million | CN¥8.95 Billion | ▼ -90.1% |
| 2024 | 0.02x | CN¥160.44 Million | CN¥10.32 Billion | ▲ +108.8% |
| 2023 | 0.01x | CN¥82.47 Million | CN¥11.07 Billion | ▼ -82.1% |
| 2022 | 0.04x | CN¥523.07 Million | CN¥12.58 Billion | ▲ +56.8% |
| 2021 | 0.03x | CN¥442.95 Million | CN¥16.70 Billion | ▲ +38.3% |
| 2020 | 0.02x | CN¥414.96 Million | CN¥21.65 Billion | ▼ -79.7% |
| 2019 | 0.09x | CN¥2.09 Billion | CN¥22.21 Billion | ▲ +1200.2% |
| 2018 | -0.01x | CN¥-201.66 Million | CN¥23.53 Billion | ▲ +93.9% |
| 2017 | -0.14x | CN¥-2.42 Billion | CN¥17.31 Billion | ▲ +35.1% |
| 2016 | -0.22x | CN¥-1.76 Billion | CN¥8.15 Billion | ▼ -152.5% |
| 2015 | -0.09x | CN¥-466.26 Million | CN¥5.46 Billion | ▼ -101.2% |
| 2014 | -0.04x | CN¥-163.62 Million | CN¥3.85 Billion | ▲ +56.6% |
| 2013 | -0.10x | CN¥-274.46 Million | CN¥2.80 Billion | ▼ -26.5% |
| 2012 | -0.08x | CN¥-170.52 Million | CN¥2.20 Billion | ▲ +77.2% |
| 2011 | -0.34x | CN¥-475.03 Million | CN¥1.40 Billion | ▼ -668.9% |
| 2010 | 0.06x | CN¥70.56 Million | CN¥1.18 Billion | ▼ -21.7% |
| 2009 | 0.08x | CN¥61.38 Million | CN¥805.78 Million | ▲ +192.2% |
| 2008 | -0.08x | CN¥-49.88 Million | CN¥603.64 Million | — |